Interleukin (IL)-2, IL-6, IL-17, and IL-37 have been considered as potentialbiomarkers of LN.(37) However,further studies are required to determine the role of these markers inpredicting the activity of LN or renal function decline. Here, IL17A is linked to lobular neoplasia.